BioSpecifics Technologies names new Senior Vice President and Chief Business Officer
21 July 2020 -

US-based BioSpecifics Technologies Corp (NASDAQ: BSTC) has named Alex Monteith as its new senior vice president and chief business officer, it was reported on Monday.

Prior to joining BioSpecifics Technologies, Monteith was vice president of Business Development for Deerfield Management, LLC. He has also held the position of vice president of Business Development & Alliance Management for Achillion Pharmaceuticals Inc and was the head of United States Business Development for Helsinn Therapeutics, Inc. He has held various other business development roles at Signum Biosciences Inc, Alpharma Pharmaceuticals LLC and UCB, Inc since starting his career at Merck & Co Inc as a chemist.

Monteith is an MBA from Carnegie Mellon University and holds a BS degree in Biology from James Madison University.